Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Common Equity (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Common Equity for 17 consecutive years, with $2.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 3.41% year-over-year to $2.6 billion, compared with a TTM value of $2.6 billion through Dec 2025, up 3.41%, and an annual FY2025 reading of $2.6 billion, up 5.46% over the prior year.
  • Common Equity was $2.6 billion for Q4 2025 at Dolby Laboratories, down from $2.6 billion in the prior quarter.
  • Across five years, Common Equity topped out at $2.6 billion in Q4 2021 and bottomed at $2.3 billion in Q3 2022.
  • Average Common Equity over 5 years is $2.5 billion, with a median of $2.5 billion recorded in 2024.
  • The sharpest move saw Common Equity grew 9.49% in 2021, then fell 13.56% in 2022.
  • Year by year, Common Equity stood at $2.6 billion in 2021, then dropped by 13.24% to $2.3 billion in 2022, then rose by 3.04% to $2.4 billion in 2023, then rose by 6.55% to $2.5 billion in 2024, then increased by 3.41% to $2.6 billion in 2025.
  • Business Quant data shows Common Equity for DLB at $2.6 billion in Q4 2025, $2.6 billion in Q3 2025, and $2.6 billion in Q2 2025.